Micah T. Prochaska, MD, MSc | Image Credit: University of Chicago School of Medicine A recent secondary analysis of data from the Myocardial Ischemia and Transfusion (MINT) trial has found no difference in quality of life (QOL) outcomes between liberal versus restrictive transfusion strategies in patients with myocardial infarction (MI) and anemia.1 Thanks to advances … Read more
New findings from a real-world study has demonstrated long-term safety of secukinumab in people with psoriasis (PsO), psoriatic arthritis (PsA), and ankylosing spondylitis (AS).1 “Patients with immune-mediated inflammatory diseases such as PsO, PsA and AS, require prolonged treatment and are more susceptible to developing AEs as observed in clinical studies and case reports. Therefore, there … Read more
Nicholas Todhunter, DO Credit: AHN The neuroscience program at AHN Saint Vincent Hospital plays a vital role in providing advanced neurological care to patients in the Erie region — reducing the need to travel to a major city for many conditions. Without this local access, many would face delays in receiving life-saving or quality-of-life-enhancing treatment. … Read more
Adults aged 80 and older experience the highest prevalence of cardiovascular disease, yet the optimal blood pressure targets for this group have been unclear in clinical guidelines. Now, a new study from Yale School of Medicine (YSM) suggests that intensive blood pressure management may offer important benefits for very elderly patients. As the American population … Read more
Hannah Y. Gantz Credit: Linkedin New research has found that symptoms of psoriatic arthritis (PsA) often precede psoriasis (PsO) development and psoriasis skin lesions.1 “PsA occurs in about 30% of patients with PsO, and an additional 5%–15% of psoriasis patients may have undiagnosed PsA. The current dogma is that PsO skin lesions generally occur before … Read more
Lipid accumulation product had high potential in predicting the risk of gout/hyperuricemia in new research, offering a potentially modifiable risk factor for preventing gout.1 “Traditional metrics for evaluating obesity, such as Body Mass Index (BMI) and Waist Circumference (WC), have been widely utilized; however, they exhibit significant limitations in accurately reflecting the complex nature of … Read more
Image Credit: Adobe Stock A recent study from Sapienza University of Rome has indicated that optical coherence tomography (OCT) features such as type 2 macular neovascularization (MNV), reductions in outer nuclear layer (ONL) and central foveal thickness (CFT), and intraretinal fluid (IRF) presence at baseline could signal higher risks of retinal atrophy (RA) in treatment-naïve … Read more
Actinic keratosis represents one of modern healthcare’s most overlooked and dangerous skin conditions. With global prevalence estimates of 14% and higher rates observed in older populations and those with significant UV exposure, the precancerous condition poses a significant risk to long-term health when left untreated or undiagnosed.1 “It’s really important that not just dermatologists, but … Read more
A recent retrospective study from Zhejiang, China has indicated that triamcinolone acetonide (TA) injections may successfully prevent the onset of diabetic macular edema (DME) after pars plana vitrectomy (PPV), a common postoperative complication in patients with proliferative diabetic retinopathy (PDR).1 Macular edema is a very common complication with many ocular diseases; it manifests as accumulation … Read more
Semaglutide demonstrated notable protective effects on osteoporosis and gout in people with obesity and type 2 diabetes (T2D) in a new cohort study.1 “The impact of newer anti-obesity medications on skeletal health remains incompletely understood, particularly in populations with varying metabolic profiles,” lead investigator Jo-Ching Chen, Chung Shan Medical University Hospital, Taichung, Taiwan, and colleagues … Read more